Objective Pooled analysis of nabiximols and placebo in randomized controlled studies
(RCTs) of chronic neuropathic pain. Design Systematic review and meta-analysis. Methods …

Purpose To compare the effectiveness and tolerability of add-on treatment with nabiximols
(NBX: delta-9-tetrahydrocannabinol: cannabidiol) oromucosal spray or oral dronabinol …

Introduction: Nabiximols, a cannabinoid-based oromucosal spray, is indicated as add-on
therapy for symptomatic relief of spasticity in persons with multiple sclerosis (MS). This …

Patients with advanced cancer who have pain that responds poorly to opioid therapy pose a
clinical challenge. Nabiximols (Nabiximols is the US Adopted Name [USAN] for Sativex [GW …

Objective To compare the analgesic efficacy and side effects of the synthetic cannabinoid
nabilone with those of the weak opioid dihydrocodeine for chronic neuropathic pain. Design …

Background Neuropathic pain (NPP) is a chronic syndrome suffered by patients with
multiple sclerosis (MS), for which there is no cure. Underlying cellular mechanisms involved …

Neuropathic pain (NeP) is prevalent in patients with peripheral neuropathy (PN), regardless
of etiology. We sought to compare the efficacy of the cannabinoid nabilone as either …

Objective: The purpose of this review is to provide an update of the neuropathic pain
treatment algorithm previously published by Namaka et al. in 2004. This algorithm focuses …

Background Milnacipran is a serotonin–norepinephrine reuptake inhibitor (SNRI) that is
sometimes used to treat chronic neuropathic pain and fibromyalgia. This is an update of an …

The 20% prevalence of chronic pain in the general population is a major health concern
given the often profound associated impairment of daily activities, employment status, and …